BRIEF—Janssen to adopt Johnson & Johnson brand in UK

1 May 2024

As of May 1, Johnson & Johnson is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK.

Janssen, the company’s pharmaceutical segment, will be named Johnson & Johnson Innovative Medicine, and the medical technology segment will continue to be named Johnson & Johnson MedTech.

The transition is happening at a time when Johnson & Johnson is celebrating its storied heritage and achievements over 100 years of operation in the UK.

Johnson & Johnson has stood alongside the UK through world wars, disease outbreaks and natural disasters, proudly partnering with the National Health Service (NHS), healthcare leaders, clinicians, and patients to develop innovative treatments and technologies along the way.

More Features in Pharmaceutical